Skip To Content
Recently Viewed Companies

Alopexx Inc

Alopexx, Inc. operates as a clinical stage biotechnology company. The Company develops novel immune therapeutics for the prevention, treatment and mitigation of bacterial, fungal, and parasitic infections that express the antigenic target poly N-acetyl glucosamine (PNAG). Alopexx serves customers worldwide.